ALKS

SEC source: 0001520262-26-000131 · form4.xml · derivative · entry 3

Reed Joshua · CIK 0001746541 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,492

Underlying: Ordinary Shares · 9,164 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share.

F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share.

F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 10/8/2026.

F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 10/8/2026.

SEC source: 0001520262-26-000131 · form4.xml · nonDerivative · entry 2

Reed Joshua · CIK 0001746541 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,095

SEC source: 0001520262-26-000131 · form4.xml · nonDerivative · entry 1

Reed Joshua · CIK 0001746541 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share.

SEC source: 0001520262-26-000130 · form4.xml · derivative · entry 2

Whitaker Anne Clem · CIK 0001593283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,998

Underlying: Ordinary Shares · 17,998 shares

Expires 2036-10-07

F3 · derivative.exercise_date: Shares subject to the stock option award vest in three equal annual installments commencing on 10/7/2027.

SEC source: 0001520262-26-000130 · form4.xml · derivative · entry 1

Whitaker Anne Clem · CIK 0001593283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,239

Underlying: Ordinary Shares · 7,239 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share.

F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 10/7/2027.

F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 10/7/2027.

SEC source: 0001520262-26-000127 · form4.xml · nonDerivative · entry 1

Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 221,388

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025.

SEC source: 0001520262-26-000120 · form4.xml · nonDerivative · entry 1

Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 223,422

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025.

SEC source: 0001520262-26-000118 · form4.xml · derivative · entry 3

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,276

Underlying: Ordinary Shares · 5,000 shares

Expires 2032-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

F4 · derivative.exercise_date: These options are fully vested in accordance with their terms.

SEC source: 0001520262-26-000118 · form4.xml · nonDerivative · entry 2

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,389

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.8269 to $47.3197. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.

SEC source: 0001520262-26-000118 · form4.xml · nonDerivative · entry 1

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,389

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

SEC source: 0001520262-26-000116 · form4.xml · nonDerivative · entry 2

Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,193

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/15/2026.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.61 to $49.79. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.

SEC source: 0001520262-26-000116 · form4.xml · nonDerivative · entry 1

Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,857

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/15/2026.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.6092 to $49.49. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.

SEC source: 0001520262-26-000113 · form4.xml · derivative · entry 2

Jackson Blair Curtis · CIK 0001842348 · Director · President & CEO, Alkermes plc

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,305

Underlying: Ordinary Shares · 124,305 shares

Expires 2036-08-05

F1 · kind: This award was granted in connection with the reporting person's appointment as President and Chief Executive Officer.

F3 · derivative.exercise_date: Shares underlying the stock option shall vest and become exercisable, if at all, in two tranches based upon the closing price of an ordinary share of Alkermes plc, as reported by the Nasdaq Global Select Market or another national securities exchange on which Alkermes plc's ordinary shares are listed, trading at certain pre-specified levels for 30 consecutive trading days, subject in each case to the reporting person's completion of two years of continuous service (or less, in the event of a change in control) in the role of President and Chief Executive Officer. This award expires ten years from the date of grant.

SEC source: 0001520262-26-000113 · form4.xml · derivative · entry 1

Jackson Blair Curtis · CIK 0001842348 · Director · President & CEO, Alkermes plc

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,229

Underlying: Ordinary Shares · 93,229 shares

Expires 2036-08-05

F1 · kind: This award was granted in connection with the reporting person's appointment as President and Chief Executive Officer.

F2 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 8/5/2027.

SEC source: 0001520262-26-000111 · form4.xml · derivative · entry 6

snyderman nancy lynn MD · CIK 0001675198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 16,524 shares

Expires 2026-09-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested in accordance with their terms.

SEC source: 0001520262-26-000111 · form4.xml · derivative · entry 5

snyderman nancy lynn MD · CIK 0001675198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 27,948 shares

Expires 2026-09-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested in accordance with their terms.

SEC source: 0001520262-26-000111 · form4.xml · nonDerivative · entry 3

snyderman nancy lynn MD · CIK 0001675198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,395

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.07 to $50.70. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.

SEC source: 0001520262-26-000111 · form4.xml · nonDerivative · entry 2

snyderman nancy lynn MD · CIK 0001675198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,867

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001520262-26-000111 · form4.xml · nonDerivative · entry 1

snyderman nancy lynn MD · CIK 0001675198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,343

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001520262-26-000110 · form4.xml · derivative · entry 5

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,276

Underlying: Ordinary Shares · 4,896 shares

Expires 2032-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

F3 · derivative.exercise_date: These options are fully vested in accordance with their terms.

SEC source: 0001520262-26-000110 · form4.xml · derivative · entry 4

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,252

Underlying: Ordinary Shares · 104 shares

Expires 2031-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

F3 · derivative.exercise_date: These options are fully vested in accordance with their terms.

SEC source: 0001520262-26-000110 · form4.xml · nonDerivative · entry 3

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 69,389

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

SEC source: 0001520262-26-000110 · form4.xml · nonDerivative · entry 2

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 78,389

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

SEC source: 0001520262-26-000110 · form4.xml · nonDerivative · entry 1

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,493

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

SEC source: 0001520262-26-000109 · form4.xml · nonDerivative · entry 1

Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 225,456

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025.

SEC source: 0001520262-26-000105 · form4.xml · nonDerivative · entry 1

Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 227,490

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025.

SEC source: 0001520262-26-000103 · form4.xml · derivative · entry 4

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,356

Underlying: Ordinary Shares · 5,000 shares

Expires 2031-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

F5 · derivative.exercise_date: These options are fully vested in accordance with their terms.

SEC source: 0001520262-26-000103 · form4.xml · nonDerivative · entry 3

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,389

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.10 to $52.17. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.

SEC source: 0001520262-26-000103 · form4.xml · nonDerivative · entry 2

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,089

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.06 to $52.04. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.

SEC source: 0001520262-26-000103 · form4.xml · nonDerivative · entry 1

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 82,389

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

SEC source: 0001520262-26-000101 · form4.xml · nonDerivative · entry 1

Wright Christopher I · CIK 0001838503 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,680

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/11/2026.

SEC source: 0001520262-26-000099 · form4.xml · nonDerivative · entry 1

Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 229,524

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025.

SEC source: 0001520262-26-000097 · form4.xml · derivative · entry 3

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,356

Underlying: Ordinary Shares · 5,000 shares

Expires 2031-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

F4 · derivative.exercise_date: These options are fully vested in accordance with their terms.

SEC source: 0001520262-26-000097 · form4.xml · nonDerivative · entry 2

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 77,389

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.37 to $42.19. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.

SEC source: 0001520262-26-000097 · form4.xml · nonDerivative · entry 1

Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,389

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

SEC source: 0001520262-26-000095 · form4.xml · derivative · entry 5

Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO)

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,826

Underlying: Ordinary Shares · 12,825 shares

Expires 2031-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options are fully vested in accordance with their terms.

SEC source: 0001520262-26-000095 · form4.xml · derivative · entry 4

Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO)

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,394

Underlying: Ordinary Shares · 3,392 shares

Expires 2030-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options are fully vested in accordance with their terms.

SEC source: 0001520262-26-000095 · form4.xml · nonDerivative · entry 3

Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO)

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,717

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.245 to $42.50. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.

SEC source: 0001520262-26-000095 · form4.xml · nonDerivative · entry 2

Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO)

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,934

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001520262-26-000095 · form4.xml · nonDerivative · entry 1

Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO)

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,109

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001520262-26-000092 · form4.xml · derivative · entry 5

Wilson Frank Anders · CIK 0001462948 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 6,142 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share.

F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share.

F3 · derivative.exercise_date: This award is fully vested in accordance with its terms.

F3 · derivative.expiration_date: This award is fully vested in accordance with its terms.

SEC source: 0001520262-26-000092 · form4.xml · nonDerivative · entry 2

Wilson Frank Anders · CIK 0001462948 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,751

SEC source: 0001520262-26-000092 · form4.xml · nonDerivative · entry 1

Wilson Frank Anders · CIK 0001462948 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,226

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share.

SEC source: 0001520262-26-000089 · form4.xml · derivative · entry 5

Lurker Nancy · CIK 0001450485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 6,142 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share.

F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share.

F3 · derivative.exercise_date: This award is fully vested in accordance with its terms.

F3 · derivative.expiration_date: This award is fully vested in accordance with its terms.

SEC source: 0001520262-26-000089 · form4.xml · nonDerivative · entry 2

Lurker Nancy · CIK 0001450485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,222

SEC source: 0001520262-26-000089 · form4.xml · nonDerivative · entry 1

Lurker Nancy · CIK 0001450485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,697

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share.

SEC source: 0001520262-26-000088 · form4.xml · derivative · entry 5

LAURENCIN CATO T · CIK 0001444810 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 6,142 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share.

F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share.

F3 · derivative.exercise_date: This award is fully vested in accordance with its terms.

F3 · derivative.expiration_date: This award is fully vested in accordance with its terms.

SEC source: 0001520262-26-000088 · form4.xml · nonDerivative · entry 2

LAURENCIN CATO T · CIK 0001444810 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,769

SEC source: 0001520262-26-000088 · form4.xml · nonDerivative · entry 1

LAURENCIN CATO T · CIK 0001444810 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,244

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share.

SEC source: 0001520262-26-000090 · form4.xml · derivative · entry 6

MCKEON BRIAN P · CIK 0001219445 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 6,142 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share.

F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share.

F4 · derivative.exercise_date: This award is fully vested in accordance with its terms.

F4 · derivative.expiration_date: This award is fully vested in accordance with its terms.